Carle Cancer Center NCI Community Oncology Research Program (NCORP)

卡尔癌症中心 NCI 社区肿瘤​​学研究计划 (NCORP)

• 批准号: 10670223
• 负责人: KENDRITH Martin ROWLAND
• 金额: $ 219.83万
• 依托单位: CARLE FOUNDATION
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-08 至 2025-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10670223
• 关键词: Advanced Malignant Neoplasm; Cancer Center; Cancer Control; Clinical Research; Clinical Trials; Communities; Community Clinical Oncology Program; Data; Detection; Discipline; Ensure; Family; Foundations; Funding; Goals; Health system; Healthcare; Healthcare Systems; Hospitals; Illinois; Image; Indiana; Individual; Infrastructure; Institution; Integrated Health Care Systems; Investments; Medical center; Mentors; Mission; National Cancer Institute; Oncology; Patient-Focused Outcomes; Population; Population Heterogeneity; Prevention; Primary Care; Process; Provider; Quality of life; Research; Research Institute; Rural Population; Training; Translational Research; cancer care; cancer health disparity; cancer prevention; care delivery; community based participatory research; community setting; data mining; electronic data; evidence base; experience; improved; medical specialties; member; multidisciplinary; novel; programs; recruit; screening

SUMMARY ABSTRACT Carle Cancer Center in Urbana, Illinois, a current NCI Community Oncology Research Program (NCORP), is applying for renewed funding to continue its commitment to provide cancer prevention, control, screening, and care delivery research in the community setting. Joining in our efforts are affiliate institutions, Rush-Copley Medical Center in Aurora, Illinois and St. Vincent Anderson in Anderson, Indiana. Together, the NCORP affiliate institutions' objectives are to engage institutions and communities in the participation of research to advance all aspects of cancer care. The goal is to optimize the personal and institutional advances in health care through research that becomes readily transferable across other health care systems and populations for the benefit of all. The Carle NCORP is devoted to engage all members and communities to be represented in clinical and translational research. Over the next six years, the Carle NCORP will continue to recruit, train, and mentor any population or health system in the region to similarly participate in clinical research. Carle's strength is its highly integrated health care system, from top to bottom (organizationally and electronically), comprised of 928 primary care and specialty providers, all invested in a research culture. The Carle NCORP's three main strengths are cancer control, prevention, and care delivery research, novel imaging, and capabilities to acquire bio-specimens. Attributes in place to ensure a successful NCORP include: • Over 35 years of community research oncology experience • Multi-disciplinary and multi-institutional integration • Significant rural and diverse population in eastern Illinois and portions of Indiana • High accrual particularly with cancer control, prevention, and care delivery trials • Cross discipline research initiatives at Carle Foundation Hospital, Rush Copley, and St. Vincent Anderson • Stephens Family Clinical Research Institute infrastructure and support • Institutional support for the underserved and for the research program as a whole • Affiliation with academic centers • Initiatives for imaging, bio-specimen, electronic data mining • High quality data • Strong regulatory processes

摘要 伊利诺伊州厄巴纳的Carle癌症中心是目前的NCI社区肿瘤学研究计划（NCORP）， 申请新的资金，以继续致力于提供癌症预防，控制，筛查， 在社区环境中进行护理服务研究。加入我们的努力是附属机构，拉什科普利 医疗中心在奥罗拉，伊利诺伊州和圣文森特安德森在安德森，印第安纳州。 总之，NCORP附属机构的目标是让机构和社区参与 参与研究，以推进癌症护理的各个方面。我们的目标是优化个人和 通过研究在医疗保健方面取得制度性进步，使其易于在其他医疗保健领域转移 系统和人口，造福所有人。Carle NCORP致力于吸引所有成员， 在临床和转化研究中有代表性的社区。在接下来的六年里，Carle NCORP 将继续招募、培训和指导该地区的任何人口或卫生系统， 临床研究 卡尔的优势在于其高度一体化的医疗保健系统，从上到下（组织和 电子），由928个初级保健和专业提供者组成，都投资于研究文化。的 Carle NCORP的三个主要优势是癌症控制，预防和护理提供研究，新型成像， 以及获取生物样本的能力。确保NCORP成功的属性包括： ·超过35年的社区研究肿瘤学经验 ·多学科、多机构融合 ·伊利诺伊州东部和印第安纳州部分地区的大量农村和多样化人口 ·高收益，特别是在癌症控制、预防和护理提供试验中 ·卡尔基金会医院、拉什科普利和圣文森特的跨学科研究计划 安德森 斯蒂芬斯家庭临床研究所基础设施和支持 ·为服务不足的人和整个研究计划提供机构支持 ·与学术中心的联系 ·成像、生物标本、电子数据挖掘倡议 ·高质量数据 ·强有力的监管流程

项目成果

The impact of RTOG 0614 and RTOG 0933 trials in routine clinical practice: The US Survey of Utilization of Memantine and IMRT planning for hippocampus sparing in patients receiving whole brain radiotherapy for brain metastases.

RTOG 0614 和 RTOG 0933 试验对常规临床实践的影响：美国美金刚使用情况调查和 IMRT 计划对接受全脑放疗的脑转移患者的海马保留。

• DOI: 10.1016/j.cct.2015.12.013
• 发表时间: 2016
• 期刊: Contemporary clinical trials
• 影响因子: 2.2
• 作者: Slade,AlexanderN;Stanic,Sinisa
• 通讯作者: Stanic,Sinisa